image
NeoGenomics, Inc. NEO
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 7.7808
-1.91 %
$ 200 M
Market Cap
-12.61
P/E
BALANCE SHEET
1.64 B ASSETS
-2.57%
Growth Rates
1Year -2.57%
3Years -4.31%
5Years 18.22%
7Years 25.01%
10Years 35.06%
736 M LIABILITIES
-0.54%
Growth Rates
1Year -0.54%
3Years -1.14%
5Years 29.49%
7Years 27.03%
10Years 42.91%
902 M EQUITY
-4.16%
Growth Rates
1Year -4.16%
3Years -6.62%
5Years 12.20%
7Years 23.53%
10Years 31.05%
BALANCE SHEET DECOMPOSITION
Balance Sheet NeoGenomics, Inc.
image
Current Assets 596 M
Cash & Short-Term Investments 387 M
Receivables 151 M
Other Current Assets 58.6 M
Non-Current Assets 1.04 B
Long-Term Investments 0
PP&E 174 M
Other Non-Current Assets 868 M
23.62 %9.19 %3.58 %10.60 %53.01 %Total Assets$1.6b
Current Liabilities 301 M
Accounts Payable 21.6 M
Short-Term Debt 201 M
Other Current Liabilities 78.9 M
Non-Current Liabilities 434 M
Long-Term Debt 340 M
Other Non-Current Liabilities 94.1 M
2.94 %27.29 %10.72 %46.26 %12.79 %Total Liabilities$735.7m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Mar-2008 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000
ASSETS
Cash & Cash Equivalents 367.0 342.5 263.2 316.8 228.7 173.0 9.8 12.8 12.5 23.4 33.7 4.8 1.9 2.6 1.1 1.6 0.5 0.2 0.1 10.9 K 0.1 25.1 K 0 77.2 K 186
Short Term Investments 19.8 72.7 174.8 198.6 67.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 150.5 131.3 119.7 112.1 106.8 94.2 76.9 60.4 55.5 48.9 20.5 18.7 14.0 7.9 5.2 4.6 2.9 3.2 1.5 0.6 56.5 K 63.9 K 40.1 K 0 0
Inventory 26.7 24.2 24.3 23.4 29.5 14.4 8.7 7.5 6.3 5.1 2.6 2.3 1.9 1.2 0.9 0.6 0.5 0.3 0.1 60 K 15.1 K 10.6 K 19.3 K 0 0
Other Current Assets 31.9 26.2 23.3 30.6 16.1 9.1 8.3 5.2 4.5 4.9 3.1 2.8 0.8 1.5 1.5 1.7 0.5 0.4 0.1 58.5 K 12.1 K 2.63 K 2 K 1.3 K 0
Total Current Assets 596.0 596.8 605.3 681.5 448.7 290.7 103.7 85.0 78.8 99.0 58.7 27.5 18.6 13.2 8.7 8.5 4.4 4.2 1.9 0.7 0.2 0.1 61.4 K 78.5 K 186
PP&E 173.7 183.8 198.6 211.7 151.9 90.7 60.9 36.5 34.0 34.6 15.1 9.7 8.6 6.6 4.8 4.3 2.9 2.1 1.2 0.4 0.4 0.4 0.4 2.83 K 0
Intangible Assets 339.7 373.1 408.3 442.3 120.7 126.6 140.0 74.2 77.1 87.8 4.2 2.6 2.8 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 522.8 522.8 522.8 527.1 211.1 198.6 197.9 147.0 147.0 146.4 2.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 31 K (55.5) 29.6 (15.6) (22.5) (6.3) (15.0) (16.7) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 5.9 4.7 (29.7) 7.2 21.0 2.8 2.5 0.7 0.2 0.1 0.1 0.2 83 K 0.1 74 K 85.6 K 64.5 K 0.3 33.9 K 18 K 2.68 K 7.22 K 3.92 K 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 181 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 638.0 1 681.2 1 740.0 1 869.8 988.3 709.5 505.0 343.3 337.1 368.0 81.1 39.9 30.1 19.9 13.7 12.9 7.3 6.5 3.1 1.1 0.6 0.5 0.4 81.3 K 186
LIABILITIES
Accounts Payable 21.6 20.3 20.5 17.9 25.0 19.6 17.8 10.4 16.8 12.5 6.3 4.2 3.6 2.5 1.9 2.0 1.5 1.8 0.7 0.5 96.2 K 70.3 K 0.1 19.3 K 10.5 K
Short Term Debt 200.8 5.6 6.7 8.0 7.8 8.4 20.5 9.0 8.7 14.0 3.2 7.1 10.7 6.0 5.4 2.0 1.8 0.2 1.7 0 0 0 13.5 K 0 0
Other Current Liabilities 78.4 68.2 55.2 56.1 39.2 34.3 21.8 17.0 12.6 13.6 4.9 2.9 3.5 2.9 1.8 1.8 1.1 1.3 0.2 0.1 0.8 0.1 0.2 0.2 0.1
Total Current Liabilities 301.2 96.3 89.9 87.2 73.2 63.9 60.9 35.1 59.9 40.1 14.6 14.3 17.8 11.4 9.2 5.8 4.4 3.4 2.6 0.7 1.0 0.3 0.4 0.2 0.1
Long Term Debt 340.3 606.1 604.3 604.8 211.4 115.9 98.1 96.4 97.4 57.4 5.3 3.3 3.1 2.6 1.3 1.5 1.4 0.8 0.4 1.4 0 0.6 0 0 0
Deferred Tax Income 21.5 24.3 34.8 55.5 5.4 15.6 22.5 6.3 15.0 32.4 0.8 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 72.6 13.0 13.1 14.0 9.5 6.8 3.1 7.0 0 0 0 0 0 0 0 272 0 0 0 0 0 0 0 0 0
Total Liabilities 735.7 739.7 742.0 761.5 294.0 202.1 184.6 137.8 150.5 129.8 20.7 18.2 20.9 14.1 10.5 7.3 5.8 4.2 3.1 2.1 1.0 0.9 0.4 0.2 0.1
EQUITY
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 94 K 80 K 79 K 76 K 60 K 49 K 45 K 43 K 37 K 37.2 K 32.1 K 31.4 K 27.1 K 22.8 K 21.5 K 18.4 K 4.48 K 0.4 1.3
Retained Earnings (325.8) (247.1) (159.1) (14.8) (7.2) (11.4) (51.3) (57.5) (52.5) (21.9) (19.4) (20.5) (22.6) (22.6) (21.5) (18.2) (15.9) (14.5) (11.2) (11.0) (10.0) (8.7) (8.7) (8.1) (1.4)
Other Accumulative Comprehensive Income/Loss (0.2) (1.7) (3.9) (0.6) 10 K (1.6) (0.6) 0.3 (27.1) (26.5) (19.8) (14.5) (10.3) (6.7) (4.6) (2.8) 0 0 (0.1) 2.68 K 28.6 K (0.5) 38.4 K (3.8) 0
Total Equity 902.3 941.5 998.0 1 108.3 694.3 507.4 320.4 205.5 186.6 238.1 60.4 21.7 9.2 5.9 3.1 5.6 1.5 2.3 54.5 K (1.0) (0.4) (0.4) 23.3 K (0.1) (0.1)
Total Liabilities and Equity 1 638.0 1 681.2 1 740.0 1 869.8 988.3 709.5 505.0 343.3 337.1 368.0 81.1 39.9 30.1 19.9 13.7 12.9 7.3 6.5 3.1 1.1 0.6 0.5 0.4 81.3 K 186
SHARES OUTSTANDING
Common Shares Outstanding 25.3 25.1 24.8 24.0 21.7 20.1 18.3 15.6 15.4 12.1 10.7 9.7 9.0 8.6 7.5 6.9 6.3 6.0 5.2 4.5 4.0 2.9 0.8 0.8 0.2